Debby Kruijsen
Vorstandsvorsitzender bei Immunoprecise Antibodies (Europe) BV
Ursprung des Netzwerks ersten Grades von Debby Kruijsen
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Immunoprecise Antibodies (Europe) BV
Immunoprecise Antibodies (Europe) BV Pharmaceuticals: MajorHealth Technology Immunoprecise Antibodies (Europe) BV operates as a pharmaceutical company that specializes in antibiotics. Its services include antigen selection, antibody generation, antibody optimization, antibody production, antibody processing and assay development. The company was founded in 2004 and is headquartered in Oss, the Netherlands.
1
| Private Company | Pharmaceuticals: Major | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Debby Kruijsen
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Citryll BV
Citryll BV Miscellaneous Commercial ServicesCommercial Services Citryll BV is a private pharmaceutical company located in Oss, the Netherlands, at the Pivot Park. Citryll is dedicated to developing and commercializing therapeutics that target netosis and NETs, with a focus on immune-mediated inflammatory diseases. The Dutch company's lead antibody, Cit-013, has a unique dual mode of action and proprietary NET biomarker assays, making it a promising drug for rheumatoid arthritis and hidradenitis suppurativa. The initial clinical trials with Cit-013 are expected to provide the foundation for a new treatment paradigm for immune-mediated inflammatory diseases. The company was founded in 2015 by Helmuth van Es, Renato Chirivi, and the late Jos Raats of ModiQuest. | Miscellaneous Commercial Services | Director/Board Member |
Statistik
International
Niederlande | 2 |
Sektoral
Commercial Services | 2 |
Operativ
Chief Executive Officer | 1 |
President | 1 |
Director/Board Member | 1 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Jos Raats | 2 |
- Börse
- Insiders
- Debby Kruijsen
- Unternehmensverbindungen